Results 241 to 250 of about 26,275 (301)
Ovulation induction and cancer risk
Fertility and Sterility, 2005 Objective: To review and critique the literature regarding ovulation induction and cancer risk. Design: Identification of relevant clinical and epidemiological literature through PubMed and other sources.
Louise A Brinton +2 more
exaly +2 more sources
Human Reproduction Update, 2019 BACKGROUND: Polycystic ovary syndrome (PCOS) is the most frequent cause of anovulatory infertility. In women with PCOS, effective ovulation induction serves as an important first-line treatment for anovulatory infertility.
Rui Wang, Wentao Li, Richard S Legro
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Obstetrical & Gynecological Survey, 1976
A treatment plan utilizing placebo, cyclical steroid therapy, clomiphene citrate, and human pituitary gonadotropin is outlined for the induction of ovulation in carefully selected potentially fertile women. Such a plan minimizes any risk with the potentially hazardous ovulatory stimulants.
J, Evans, L, Townsend
openaire +2 more sources
A treatment plan utilizing placebo, cyclical steroid therapy, clomiphene citrate, and human pituitary gonadotropin is outlined for the induction of ovulation in carefully selected potentially fertile women. Such a plan minimizes any risk with the potentially hazardous ovulatory stimulants.
J, Evans, L, Townsend
openaire +2 more sources
Obstetrics and Gynecology Clinics of North America, 1987
Methods to induce ovulation in anovulatory women have blossomed over the last three decades. The introduction of clomiphene citrate in 1960 allowed us for the first time to provoke follicle development in patients with normo or hyperestrogenic forms of anovulation. The development of human menopausal gonadotropins in the early 1960s gave us a much more
J L, Kennedy, E Y, Adashi
openaire +2 more sources
Methods to induce ovulation in anovulatory women have blossomed over the last three decades. The introduction of clomiphene citrate in 1960 allowed us for the first time to provoke follicle development in patients with normo or hyperestrogenic forms of anovulation. The development of human menopausal gonadotropins in the early 1960s gave us a much more
J L, Kennedy, E Y, Adashi
openaire +2 more sources
Acta Obstetricia et Gynecologica Scandinavica, 1975
Ovulation has been induced by clomiphene citrate and human gonadotropins in infertile women. Clomiphene should be the first choice in anovulatory women with active ovaries as indicated by basic levels of estrogens in blood or urine, in women with post-pill amenorrhea even if their ovaries are quiescent and in women with functional abnormalities of the ...
openaire +3 more sources
Ovulation has been induced by clomiphene citrate and human gonadotropins in infertile women. Clomiphene should be the first choice in anovulatory women with active ovaries as indicated by basic levels of estrogens in blood or urine, in women with post-pill amenorrhea even if their ovaries are quiescent and in women with functional abnormalities of the ...
openaire +3 more sources
THE INDUCTION OF OVULATION BY TAMOXIFEN
BJOG: An International Journal of Obstetrics & Gynaecology, 1973SummaryA new antiâoestrogen, tamoxifen, has been synthesized and is available for clinical trials. Its value in the treatment of anovulatory infertility has been assessed in 32 patients. A total of 26 patients apparently ovulated, 16 patients conceived during a treatment cycle, and 2 patients became pregnant during the first spontaneous cycle ...
J G, Williamson, J D, Ellis
openaire +2 more sources
Expert Opinion on Pharmacotherapy, 2003
Anovulation, a common cause of female infertility, is a highly curable condition. Presented here is a simple treatment-orientated diagnostic scheme. Anovulatory women with low endogenous oestradiol and follicle stimulating hormone (FSH) are treated with either pulsatile gonadotrophin releasing hormone (GnRH) or gonadotropins, and women with eu ...
openaire +2 more sources
Anovulation, a common cause of female infertility, is a highly curable condition. Presented here is a simple treatment-orientated diagnostic scheme. Anovulatory women with low endogenous oestradiol and follicle stimulating hormone (FSH) are treated with either pulsatile gonadotrophin releasing hormone (GnRH) or gonadotropins, and women with eu ...
openaire +2 more sources
Experience with induction of ovulation
American Journal of Obstetrics and Gynecology, 1970Abstract One hundred and thirty-five patients diagnosed as ovulatory failure have been treated in our clinic since 1966. One hundred and eighteen of these have been treated with clomiphene citrate, or more recently, its cisisomer, and 17 patients with long-standing secondary amenorrhea or primary amenorrhea have been treated with human menopausal ...
S C, MacLeod +3 more
openaire +2 more sources
Clinical Obstetrics and Gynecology, 2000
In the woman with anovulation and polycystic ovarian syndrome, there are many options for ovulation induction. Treatment should be individualized, but clomiphene citrate is an excellent first-line agent. In the woman resistant to clomiphene citrate, combination therapy often results in pregnancy.
openaire +2 more sources
In the woman with anovulation and polycystic ovarian syndrome, there are many options for ovulation induction. Treatment should be individualized, but clomiphene citrate is an excellent first-line agent. In the woman resistant to clomiphene citrate, combination therapy often results in pregnancy.
openaire +2 more sources
Induction of ovulation with cisclomiphene
American Journal of Obstetrics and Gynecology, 1973Abstract Thirty-seven infertile patients with ovulatory defects have been treated with cisclomiphene at dosages varying from 10 to 140 mg. per day. The over-all ovulatory rate was 78.1 per cent with a pregnancy rate of 51.3 per cent. The results of our investigation with cisclomiphene are presented in detail and are compared with our previous ...
J, Van Campenhout +3 more
openaire +2 more sources